Compass Therapeutics (CMPX) Net Cash Flow Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | Compass Therapeutics | 418.47 Mn | 223.78 Mn | - | 1,107.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,107.19% |
| Dec 31, 2025 | -354.65% |
| Sep 30, 2025 | 30.01% |
| Jun 30, 2025 | -326.04% |
| Mar 31, 2025 | -339.53% |
| Dec 31, 2024 | 198.64% |
| Sep 30, 2024 | 61.15% |
| Jun 30, 2024 | 44.90% |
| Mar 31, 2024 | 93.00% |
| Dec 31, 2023 | -133.57% |
| Sep 30, 2023 | 214.26% |
| Jun 30, 2023 | 92.96% |
| Mar 31, 2023 | 2.66% |
| Dec 31, 2022 | -84.46% |
| Sep 30, 2022 | -71.21% |
| Jun 30, 2022 | -1,206.85% |
| Mar 31, 2022 | -8.57% |
| Sep 30, 2021 | -118.86% |
| Jun 20, 2021 | -121.03% |
| Mar 31, 2021 | 3.60% |
| Sep 30, 2020 | 214.32% |
| Jun 30, 2020 | 303.39% |
| Dec 31, 2019 | -266.68% |
| Jun 30, 2019 | -272,538.11% |